Башкы Биз жөнүндө Кызматтар Байланыштар
 

NVZMY Outperforms

NVZMY Outperforms

NVZMY holds a Zacks Rank of #2 (Buy) versus HWKN’s #3 (Hold), reflecting a sharper earnings‑outlook improvement for the former. Forward‑looking valuation multiples reinforce NVZMY’s relative appeal: its forward P/E sits at 24.53 compared with HWKN’s 31.23, and its PEG ratio is 1.11 against HWKN’s 1.95. The price‑to‑book metric also favours NVZMY, with a P/B of 2.26 versus HWKN’s 5.04. These superior valuation numbers underpin NVZMY’s Value grade of B, whereas HWKN receives a C. The aggregate data position NVZMY as the more attractive value option in the current comparison.
04/02/2026 | Novozymes A/S